Abbott Laboratories Faces Class-Action Lawsuit Over PediaSure Marketing Claims
A federal judge ruled that Abbott Laboratories (ABT) must face a class-action lawsuit over its marketing of PediaSure as 'clinically proven' to help children grow. The court found the labeling and advertising could mislead consumers into interpreting growth in terms of height or weight gain.
Tickers: $ABT